C-myc and PCNA expression in lung cancer and its significance
YI Huancong
Abstract
YI Huancong
Abstract
Objective:To investigate the expression of C-myc and PCNA(proliferating cell nuclear antigen) in lung cancer and normal lung tissue or lung tissue of bullae and the relationship to the development of lung cancer.Methods: Immunohistochemical staining was used to measure expression of C-myc and PCNA in 50 patients with primary lung cancer(squamous cell carcinoma in 24 cases,19 cases of adenocarcinoma,adenosquamous carcinoma in 4 cases,3 cases of small cell lung cancer) and 16 normal lung tissues or lung bullae tissue.Results: The expression of C-myc,PCNA positive rates were 66%(33/50),74%(37/50) in total of 50 cases of primary lung cancer,no expression of two antibodies observed in normal tissue.The expression of C-myc and PCNA positive rate was significantly higher in lung cancer than lung tissue,and there was no expression of C-myc in 3 cases of small cell lung cancer.Conclusion: C-myc expression in lung cancer was no correlation to PCNA;increased expression of C-myc and PCNA which was developed in the early stage in lung cancer had no association with the staging of lung cancer;they may be related to the development of lung cancer and are helpful to the early diagnosis and molecular targeting therapy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the expression of C-myc and PCNA(proliferating cell nuclear antigen) in lung cancer and normal lung tissue or lung tissue of bullae and the relationship to the development of lung cancer.Methods: Immunohistochemical staining was used to measure expression of C-myc and PCNA in 50 patients with primary lung cancer(squamous cell carcinoma in 24 cases,19 cases of adenocarcinoma,adenosquamous carcinoma in 4 cases,3 cases of small cell lung cancer) and 16 normal lung tissues or lung bullae tissue.Results: The expression of C-myc,PCNA positive rates were 66%(33/50),74%(37/50) in total of 50 cases of primary lung cancer,no expression of two antibodies observed in normal tissue.The expression of C-myc and PCNA positive rate was significantly higher in lung cancer than lung tissue,and there was no expression of C-myc in 3 cases of small cell lung cancer.Conclusion: C-myc expression in lung cancer was no correlation to PCNA;increased expression of C-myc and PCNA which was developed in the early stage in lung cancer had no association with the staging of lung cancer;they may be related to the development of lung cancer and are helpful to the early diagnosis and molecular targeting therapy.
Key concepts: Proliferating cell nuclear antigen, Lung cancer, Immunohistochemistry, Adenosquamous carcinoma, Adenocarcinoma, Lung, Pathology, Cancer